Actively Recruiting

Phase 1
Phase 2
Age: 18Years - 60Years
All Genders
Healthy Volunteers
NCT05264025

Fexofenadine in Patients With Active Rheumatoid Arthritis

Led by October 6 University · Updated on 2025-07-31

80

Participants Needed

2

Research Sites

187 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Rheumatoid arthritis (RA) is an inflammatory autoimmune polyarthritis affecting ∼1% of the world population, resulting in the loss of joint function and progressive structural damage in affected joints. Fexofenadine has been widely used to treat various allergic diseases, like allergic rhinitis, conjunctivitis and chronic idiopathic urticaria. the molecular mechanisms underlying fexofenadine mediated inhibition of TNF-α signalling

CONDITIONS

Official Title

Fexofenadine in Patients With Active Rheumatoid Arthritis

Who Can Participate

Age: 18Years - 60Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Moderate to severe rheumatoid arthritis with disease activity score-28 joints (DAS-28) > 3.2
  • Age between 18 and 60 years with active disease diagnosed by an experienced rheumatologist
  • Currently treated with disease-modifying anti-rheumatic drugs (DMARDs), not receiving cytokine inhibitors
  • Signed informed consent and willingness to accept randomization to any treatment arm
Not Eligible

You will not qualify if you...

  • History of biological DMARDs use
  • Presence or history of acute heart disease, liver disease, kidney disease, or COPD
  • Allergy or intolerance to fexofenadine or methotrexate
  • Alcohol abuse
  • Recent changes in medication dosage or type
  • Current use of hormone replacement therapy, warfarin, or other anticoagulants

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Beni-Suef Hospital

Banī Suwayf, Egypt

Actively Recruiting

2

Faculty of Medicine - Beni Suef Hospital

Banī Suwayf, Egypt

Actively Recruiting

Loading map...

Research Team

A

Ahmed Ismaeel

CONTACT

E

Engy Wahsh

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here